{"date":"2025-05-26","count":19,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-3118-2025-05-26-2303-bww4av","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2025-05-26","time":"23:03:32","subject":"公告本公司114年股東常會全面改選董事(含獨立董事)當選名單","clause":"第6款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：進階（3118），2025-05-26 23:03，「公告本公司114年股東常會全面改選董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2025-05-26-2250-17atqvp","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2025-05-26","time":"22:50:02","subject":"公告本公司薪資報酬委員會之委員任期屆滿改選","clause":"第6款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：進階（3118），2025-05-26 22:50，「公告本公司薪資報酬委員會之委員任期屆滿改選」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2025-05-26-2248-1fh57gu","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2025-05-26","time":"22:48:18","subject":"公告本公司審計委員會之委員任期屆滿改選","clause":"第6款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：進階（3118），2025-05-26 22:48，「公告本公司審計委員會之委員任期屆滿改選」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2025-05-26-2239-9769qc","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2025-05-26","time":"22:39:15","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：進階（3118），2025-05-26 22:39，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2025-05-26-2233-cghp06","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2025-05-26","time":"22:33:23","subject":"本公司發言人職務調整公告","clause":"第8款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：進階（3118），2025-05-26 22:33，「本公司發言人職務調整公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2025-05-26-1837-t6rqxo","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2025-05-26","time":"18:37:36","subject":"公告本公司114年股東常會重要決議","clause":"第18款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：進階（3118），2025-05-26 18:37，「公告本公司114年股東常會重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2025-05-26-1831-1cugv11","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-05-26","time":"18:31:29","subject":"公告本公司114年股東常會通過解除本公司董事及其代表人競業禁止之限制案","clause":"第22款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2025-05-26 18:31，「公告本公司114年股東常會通過解除本公司董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2025-05-26-1831-ds864w","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-05-26","time":"18:31:15","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2025-05-26 18:31，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2025-05-26-1829-1vf5upf","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-05-26","time":"18:29:27","subject":"代重要子公司育禾管理顧問股份有限公司公告股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2025-05-26 18:29，「代重要子公司育禾管理顧問股份有限公司公告股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2025-05-26-1826-1mnbu64","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2025-05-26","time":"18:26:44","subject":"公告本公司董事會重要決議","clause":"第53款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：進階（3118），2025-05-26 18:26，「公告本公司董事會重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2025-05-26-1826-1u4o1fq","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2025-05-26","time":"18:26:08","subject":"公告本公司113年度除息基準日","clause":"第14款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：進階（3118），2025-05-26 18:26，「公告本公司113年度除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2025-05-26-1746-196mvw2","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2025-05-26","time":"17:46:43","subject":"公告本公司114年股東常會通過解除新任董事競業禁止案","clause":"第21款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2025-05-26 17:46，「公告本公司114年股東常會通過解除新任董事競業禁止案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2025-05-26-1746-6wjzs6","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2025-05-26","time":"17:46:03","subject":"公告114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2025-05-26 17:46，「公告114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2025-05-26-1620-1f5rxz4","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2025-05-26","time":"16:20:48","subject":"代子公司御華生醫股份有限公司公告自主研發新藥NBM-BMX針對膠質母細胞瘤(腦癌)單藥或與TMZ合併用藥之1b/2臨床試驗於5月26日完成期中分析報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2025-05-26 16:20，「代子公司御華生醫股份有限公司公告自主研發新藥NBM-BMX針對膠質母細胞瘤(腦癌)單藥或與TMZ合併用藥之1b/2臨床試」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2025-05-26-1606-4qlxv3","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2025-05-26","time":"16:06:45","subject":"公告本公司業務部副總經理異動","clause":"第11款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2025-05-26 16:06，「公告本公司業務部副總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2025-05-26-1432-1bhht8i","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2025-05-26","time":"14:32:53","subject":"公告本公司股東常會決議通過解除董事競業禁止之限制","clause":"第21款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2025-05-26 14:32，「公告本公司股東常會決議通過解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2025-05-26-1431-ds864w","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2025-05-26","time":"14:31:58","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2025-05-26 14:31，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6527-2025-05-26-1407-ds864w","company_id":"6527","company":"明達醫","market":"上櫃","industry":"生技醫療","date":"2025-05-26","time":"14:07:36","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：明達醫（6527），2025-05-26 14:07，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2025-05-26-1033-8gn1d","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2025-05-26","time":"10:33:48","subject":"公告本公司一一四年股東常會重要決議事項","clause":"第18款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2025-05-26 10:33，「公告本公司一一四年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}